Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion description "[Current clinically available anti-HER2 therapies are effective only in patients with HER2 amplified breast cancer, including IBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion evidence source_evidence_literature NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion SIO_000772 24886365 NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion wasDerivedFrom befree-2016 NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion wasGeneratedBy ECO_0000203 NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- befree-2016 importedOn "2016-02-19" NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.